ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

NCI’s Breast Cancer Screening Guidelines Released In Draft

September 24, 1993

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Saul Rivin Receives ACCC Clinical Research Award.

December 1, 2000

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014

Behavior Scientists To Discuss Cancer Patient Rehabilitation

January 17, 1975

McKenna Sees Budget Cuts as Threat to Year 2000 Goals Urges Stepped Up Efforts Against Tobacco Industry

April 5, 1985